Navigation Links
ACORN Research, LLC Announces Partnership with AdeptBio, LLC
Date:11/10/2011

MEMPHIS, Tenn., Nov. 10, 2011  /PRNewswire-USNewswire/ -- ACORN Research has expanded its research footprint to support advances in personalized medicine and translational research, by offering high-quality biospecimens coupled with unprecedented premium data to industry and academic research through its partnership with AdeptBio, LLC (http://www.adeptbio.com).  

ACORN Research is able to provide CRO services as needed to facilitate prospective collections of biospecimens from targeted study populations. "Development of new targeted therapies and companion diagnostics rely on availability of tissues, and increasingly biofluids, linked to deep clinical data. Banked samples are less able to meet this need, and therefore our model is aimed at optimizing prospective collections," reports Dr. Lee Schwartzberg, president of ACORN Research.

Leif Honda, AdeptBio, LLC, CEO, adds, "Researcher's needs are changing as biomarkers and companion diagnostics emerge along with new regulatory requirements. AdeptBio's relationship with ACORN Research presents an end-to-end answer to meet those needs. We are delighted to be entering into this partnership with ACORN Research as a CRO with an excellent history of success with its clients and rapport with their oncology network."

ACORN Research and AdeptBio are committed to helping the research community make significant advancements in the prevention, diagnosis, and treatment of cancer, through the provision of relevant, leading edge biospecimens and associated data.

About ACORN Research, LLC
ACORN Research, LLC is a multi-faceted research organization that combines a network of committed oncology research sites supported by centralized research processes; a bioinformatics platform that joins EMR data with ePRO data to support health outcomes research and clinical trial efficiencies; and a contract research organization focused exclusively on oncology. We offer high quality biospecimens and biofluids using unmatched sophistication in donor services.

About AdeptBio, LLC
AdeptBio, LLC is a human biospecimen contract procurement organization formed through a partnership between experts in specimen procurement, contract research, biomarker discovery, diagnostics and therapeutic R&D. AdeptBio addresses the dramatically underserved needs of pharmaceutical and diagnostic R&D companies by overcoming the challenges of supply constraints, quality, consistency, and sample diversification. The company offers complete transparency in acquisition and accrual rates across a robust network providing thorough patient data and sample characterization, and the option for longitudinal access to information. The goal of the company is to meet increasing regulatory demands by providing the most complete medical information available to researchers.

To learn more, visit http://www.acornresearch.net.

CONTACT INFORMATION:
Donna McDonnell
ACORN Research, LLC
901.260.9284
dmcdonnell@acornresearch.net
http:www.acornresearch.net


'/>"/>
SOURCE ACORN Research
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ACORN Contract Research Organization Appoints Tara Webb as Senior Director of CRO Business Development
2. ACORN CRO Continues Growth in Strong Third Quarter
3. $1.6 Million Agreement to Accelerate Fragile X Research, Inspire Hope
4. Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
5. SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO., INC.
6. CELLECTA, INC. to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research, Inc.
7. 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
8. Reportlinker Adds Frontiers in Carbohydrates Developments: Report 4; Research, Technologies; Biotechnology, Bioprocessing & Bioplastics - Food & Industrial Raw Material, January 2011
9. Hospital for Special Surgery to Host International Arthritis Summit: Frontiers in Osteoarthritis Research, Prevention and Care
10. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
11. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 25, 2017 , ... Throughout this webinar, participants will ... process development and economic goals were achieved in both industry and academic settings. ... system, along with techniques for scaling production of mesenchymal stem cells (MSCs) and ...
(Date:5/24/2017)... BOUNTIFUL, Utah (PRWEB) , ... May 24, 2017 ... ... announces the selection and implementation of CLEARAS Water Recovery’s Advanced Biological Nutrient Recovery ... a key component of a $24 million plant upgrade to sustainably meet current ...
(Date:5/24/2017)... May 23, 2017 As Ebola resurfaces in the ... deaths and 20 suspected cases now reported, a new analysis ... database, showed a correlation between the 2014 and 2017 outbreaks ... rose sharply in 2012-13, which preceded the 2014 outbreak. An ... Ebola gene Replikin counts in 2014-15, which again precedes the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Genedata, a ... anniversary, marking the occasion with a strong presence at Bio-IT World Conference & ... further extends an invitation to all attendees to view posters on the ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):